Clinical Trials on Moderate to Severe Glabellar Frown Lines
Total 328 results
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
JHM BioPharma (Tonghua) Co. , Ltd.Recruiting
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
Pacira CryoTech, Inc., a wholly owned subsidiary...CompletedGlabellar Frown Lines | Frown LinesUnited States
-
Pacira CryoTech, Inc., a wholly owned subsidiary...CompletedGlabellar Frown Lines | Frown LinesUnited States
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate-severe Glabellar Lines
-
Galderma R&DCompletedGlabellar Frown Lines | Canthal LinesUnited States
-
ATGC Co., Ltd.RecruitingGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Galderma R&DActive, not recruitingGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesRussian Federation
-
Huons Co., Ltd.UnknownGlabellar Frown LinesKorea, Republic of
-
Bonti, Inc.CompletedGlabellar Frown Lines (GL)United States
-
Protox Inc.Not yet recruitingGlabellar Frown Lines
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
IpsenCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
ATGC Co., Ltd.CompletedGlabellar Frown LinesKorea, Republic of
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.CompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001Glabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
AllerganCompletedGlabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedGlabellar Frown LinesUnited Kingdom, Germany, Austria
-
Evolus, Inc.AvaniaRecruitingGlabellar Frown LinesGermany
-
Eirion Therapeutics Inc.Active, not recruiting
-
Galderma R&DCompletedGlabellar Frown LinesGermany, United Kingdom
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Evolus, Inc.ethica Clinical Research Inc.CompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States, Canada